|U.S. National Library of Medicine
About Site Map Contact Us
|A service of the U.S. National Library of Medicine®|
Hereditary multiple exostoses
On this page:
Reviewed December 2007
What is hereditary multiple exostoses?
Hereditary multiple exostoses is a condition in which people develop multiple benign (noncancerous) bone tumors called exostoses. The number of exostoses and the bones on which they are located vary greatly among affected individuals. The exostoses are not present at birth, but approximately 96 percent of affected people develop multiple exostoses by the time they are 12 years old. Once people with hereditary multiple exostoses reach adult height and their bones stop growing, the development of new exostoses also usually stops.
Multiple exostoses can disrupt bone growth and can cause growth disturbances of the arms, hands, and legs, leading to short stature. Often these bone growth disturbances do not affect the right and left limb equally, resulting in uneven limb lengths (limb length discrepancy). Multiple exostoses may also result in pain, limited range of joint movement, and pressure on nerves, blood vessels, the spinal cord, and tissues surrounding the exostoses.
Exostoses are typically benign; however, in some instances these tumors become malignant (cancerous). Researchers estimate that people with hereditary multiple exostoses have a 1 in 20 to 1 in 200 lifetime risk of developing cancerous exostoses (sarcomas).
How common is hereditary multiple exostoses?
The incidence of hereditary multiple exostoses is estimated to be 1 in 50,000 individuals. This condition occurs more frequently, however, in some isolated populations. The incidence is approximately 1 in 1,000 in the Chamorro population of Guam and 1 in 77 in the Ojibway Indian population of Manitoba, Canada.
What genes are related to hereditary multiple exostoses?
Mutations in the EXT1 and EXT2 genes cause hereditary multiple exostoses. The EXT1 gene and the EXT2 gene provide instructions for producing the proteins exostosin-1 and exostosin-2, respectively. The two exostosin proteins bind together and form a complex found in a cell structure called the Golgi apparatus, which modifies newly produced enzymes and other proteins. In the Golgi apparatus, the exostosin 1 and 2 complex modifies a protein called heparan sulfate so it can be used by the cell.
When there is a mutation in exostosin-1 or exostosin-2, heparan sulfate cannot be processed correctly and is nonfunctional. Although heparan sulfate is involved in many bodily processes, it is unclear how the lack of this protein contributes to the signs and symptoms of hereditary multiple exostoses.
If the condition is caused by a mutation in the EXT1 gene it is called hereditary multiple exostoses type 1. A mutation in the EXT2 gene causes hereditary multiple exostoses type 2. While both type 1 and type 2 involve multiple exostoses, the severity of symptoms associated with exostoses seems to be greater in type 1.
Researchers estimate that about 15 percent of people with hereditary multiple exostoses have no mutation in either the EXT1 or the EXT2 gene. It is not known why multiple exostoses form in these people.
How do people inherit hereditary multiple exostoses?
This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
In some cases, an affected person inherits the mutation from one affected parent. Other cases may result from new mutations in the gene. These cases occur in people with no history of the disorder in their family.
Where can I find information about treatment for hereditary multiple exostoses?
These resources address the management of hereditary multiple exostoses and may include treatment providers.
Where can I find additional information about hereditary multiple exostoses?
You may find the following resources about hereditary multiple exostoses helpful. These materials are written for the general public.
You may also be interested in these resources, which are designed for healthcare professionals and researchers.
What other names do people use for hereditary multiple exostoses?
See How are genetic conditions and genes named? in the Handbook.
What if I still have specific questions about hereditary multiple exostoses?
Where can I find general information about genetic conditions?
The Handbook provides basic information about genetics in clear language.
These links provide additional genetics resources that may be useful.
What glossary definitions help with understanding hereditary multiple exostoses?
autosomal ; autosomal dominant ; benign ; cell ; enzyme ; Exostoses ; familial ; gene ; Golgi apparatus ; Heparan Sulfate ; incidence ; joint ; mutation ; new mutation ; population ; protein ; sarcoma ; sign ; stature ; sulfate ; symptom ; tissue ; tumor
You may find definitions for these and many other terms in the Genetics Home Reference Glossary.
References (5 links)
The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? in the Handbook.
|This website is regularly reviewed by members of the Scientific and Medical Advisory Board of the MHE Research Foundation.
All online submission forms use (SSL 3.0, RC4 with 128 bit encryption (High); RSA with 1024 bit exchange) Protocol with Privacy protection.
Our goal is to make this website as safe and user friendly as possible.
|The MHE Research Foundation is a participating member organization of the
United States Bone and Joint Decade, (USBJD) & the USBJD Rare Disease Patient Network
|Email the webmaster: firstname.lastname@example.org
Materials on this website are protected by copyright
Copyright © 2009 The MHE Research Foundation
|This web page was updated last on 6/21/09, 4:0O pm Eastern time
|Written consent must be obtained to attach web pages or the files attached to this website. Please email webmaster.